Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Tóm tắt
Từ khóa
Tài liệu tham khảo
Annane, 2013, Procalcitonin levels to guide antibiotic therapy in adults with non-microbiologically proven apparent severe sepsis: a randomised controlled trial, BMJ Open, 3, pii: e002186, 10.1136/bmjopen-2012-002186
Bloos, 2016, Effect of sodium selenite administration and procalcitonin-guided therapy on mortality in patients with severe sepsis or septic shock: a randomized clinical trial, JAMA Internal Medicine, 176, 1266, 10.1001/jamainternmed.2016.2514
Bouadma, 2010, Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial, Lancet, 375, 463, 10.1016/S0140-6736(09)61879-1
Branche, 2015, Serum procalcitonin measurement and viral testing to guide antibiotic use for respiratory infections in hospitalized adults: a randomized controlled trial, Journal of Infectious Diseases, 212, 1692, 10.1093/infdis/jiv252
Briel, 2008, Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care, Archives of Internal Medicine, 168, 2000, 10.1001/archinte.168.18.2000
Burkhardt, 2010, Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection, European Respiratory Journal, 36, 601, 10.1183/09031936.00163309
Christ-Crain, 2004, Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial, Lancet, 1363, 600, 10.1016/S0140-6736(04)15591-8
Christ-Crain, 2006, Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial, American Journal of Respiratory and Critical Care Medicine, 174, 84, 10.1164/rccm.200512-1922OC
Corti, 2016, Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD, International Journal of Chronic Obstructructive Pulmonary Disease, 11, 1381, 10.2147/COPD.S104051
Jong, 2016, Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial, Lancet Infectious Diseases, 16, 819, 10.1016/S1473-3099(16)00053-0
Deliberato, 2013, Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting, Diagnostic Microbiology and Infectious Disease, 76, 266, 10.1016/j.diagmicrobio.2013.03.027
Ding, 2013, Procalcitonin-guided antibiotic use in acute exacerbations of idiopathic pulmonary fibrosis, International Journal of Medical Sciences, 10, 903, 10.7150/ijms.4972
Hochreiter, 2009, Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial, Critical Care, 13, R83, 10.1186/cc7903
Kristoffersen, 2009, Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission - a randomized trial, Clinical Microbiology and Infection, 15, 481, 10.1111/j.1469-0691.2009.02709.x
Layios, 2012, Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients, Critical Care Medicine, 40, 2304, 10.1097/CCM.0b013e318251517a
Lima, 2016, Procalcitonin-guided protocol is not useful to manage antibiotic therapy in febrile neutropenia: a randomized controlled trial, Annals of Hematology, 95, 1169, 10.1007/s00277-016-2639-5
Long, 2009, Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community acquired pneumonia, Zhonghua Nei Ke Za Zhi, 48, 216
Long, 2011, Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community acquired pneumonia, Respirology, 76, 266
Long, 2014, Procalcitonin guidance for reduction of antibiotic use in patients hospitalized with severe acute exacerbations of asthma: a randomized controlled study with 12-month follow-up, Critical Care, 18, 471, 10.1186/s13054-014-0471-7
Maravić-Stojković, 2011, Procalcitonin-based therapeutic strategy to reduce antibiotic use in patients after cardiac surgery: a randomized controlled trial, Srpski Arhiv Celokupno Lekarstvo, 139, 736, 10.2298/SARH1112736M
Najafi, 2015, The comparison of procalcitonin guidance administer antibiotics with empiric antibiotic therapy in critically ill patients admitted in intensive care unit, Acta Medica Iranica, 53, 562
Nobre, 2009, Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial, American Journal of Respiratory and Critical Care Medicine, 177, 498, 10.1164/rccm.200708-1238OC
Ogasawara, 2014, Procalcitonin-guided antibiotic therapy in aspiration pneumonia and an assessment of the continuation of oral intake, Respiratory Investigation, 52, 107, 10.1016/j.resinv.2013.08.002
Oliveira, 2013, Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial, Critical Care Medicine, 41, 2336, 10.1097/CCM.0b013e31828e969f
Schroeder, 2009, Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study, Langenbecks Archives of Surgery, 394, 221, 10.1007/s00423-008-0432-1
Schuetz, 2009, Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial, JAMA, 302, 1059, 10.1001/jama.2009.1297
Shehabi, 2014, Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial, American Journal of Respiratory and Critical Care Medicine, 190, 1102, 10.1164/rccm.201408-1483OC
Stolz, 2007, Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy, Chest, 131, 9, 10.1378/chest.06-1500
Stolz, 2009, Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study, European Respiratory Journal, 34, 1364, 10.1183/09031936.00053209
Tang, 2013, Procalcitonin guided antibiotic therapy of acute exacerbations of asthma: a randomized controlled trial, BMC Infectious Diseases, 13, 596, 10.1186/1471-2334-13-596
Verduri, 2015, Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial, PLoS ONE, 10, e0118241, 10.1371/journal.pone.0118241
Wang, 2016, Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial, International Journal of Infectious Diseases, 48, 40, 10.1016/j.ijid.2016.04.024
Dharaniyadewi, 2013, Effect of semi-quantitative procalcitonin assay on the adequacy of empirical antibiotics and mortality in septic patients, Citical Care, 17, P15, 10.1186/cc12915
Esposito, 2011, Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia, Respiratory Medicine, 105, 1939, 10.1016/j.rmed.2011.09.003
Heyland, 2011, Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation, Critical Care Medicine, 39, 1792, 10.1097/CCM.0b013e31821201a5
Jensen, 2011, Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial, Critical Care Medicine, 39, 2048, 10.1097/CCM.0b013e31821e8791
Jones, 2007, Procalcitonin test in the diagnosis of bacteremia: a meta-analysis, Annals of Emergency Medicine, 50, 34, 10.1016/j.annemergmed.2006.10.020
Kook, 2012, Impact of the use of procalcitonin assay in hospitalised patients with pneumonia at a community care hospital, Infection Control and Hospital Epidemiology, 33, 424, 10.1086/664764
Liew, 2011, Use of procalcitonin (PCT) to guide discontinuation of antibiotic use in an unspecified sepsis is an antimicrobial stewardship program (ASP), European Journal of Clinical Microbiology and Infectious Diseases, 30, 853, 10.1007/s10096-011-1165-6
Liu, 2013, Clinical significance of dynamic monitoring of procalcitonin in guiding the use of antibiotics in patients with sepsis in ICU, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 25, 690
Qu, 2012, Procalcitonin is a good tool to guide duration of antibiotic therapy in patients with severe acute pancreatitis. A randomized prospective single-center controlled trial, Saudi Medical Journal, 33, 382
Saeed, 2011, Reduction in antibiotic use through procalcitonin testing in patients in the medical admission unit or intensive care unit with suspicion of infection, Journal of Hospital Infection, 78, 289, 10.1016/j.jhin.2011.03.018
Schuetz, 2010, Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey, European Journal of Clinical Microbiology and Infectious Diseases, 29, 269, 10.1007/s10096-009-0851-0
Simmonds, 2005, Meta-analysis of individual patient data from randomized trials: a review of methods used in practice, Clinical Trials, 2, 209, 10.1191/1740774505cn087oa
Simon, 2004, Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis, Clinical Infectious Diseases, 39, 206, 10.1086/421997
Stocker, 2010, Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial, Neonatology, 97, 165, 10.1159/000241296
Tang, 2007, Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis, Lancet Infectious Diseases, 7, 210, 10.1016/S1473-3099(07)70052-X
Tang, 2009, Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis, Infection, 37, 497, 10.1007/s15010-009-9034-2
Uzzan, 2006, Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis, Critical Care Medicine, 34, 1996, 10.1097/01.CCM.0000226413.54364.36
NCT02130986 Procalcitonin Antibiotic Consensus Trial (ProACT) clinicaltrials.gov/ct2/show/study/NCT02130986
NCT02261610 Pulmonary Embolism and PCT. PE-PCT Study clinicaltrials.gov/ct2/show/NCT02261610
NCT02332577 Study to compare the efficacy of pristinamycin (Pyostacine) versus amoxicillin in the treatment of acute community acquired pneumonia clinicaltrials.gov/ct2/show/NCT02332577
NCT02440828 Addition of tobramycin inhalation in the treatment of ventilator associated pneumonia (VAPORISE) clinicaltrials.gov/ct2/show/NCT02440828
NCT02787603 Procalcitonin in Early Antibiotic Interruption in Patient With Bacterial Pulmonary infeCtion and Acute Heart Failure (EPICAD) clinicaltrials.gov/ct2/show/NCT02787603
NCT02862314 PROcalcitonin Pneumonia/Pneumonitis Associated With ASPIration (PROPASPI) clinicaltrials.gov/ct2/show/NCT02862314
NCT02931409 Intraoperative PEEP optimization: effects on postoperative pulmonary complications and inflammatory response clinicaltrials.gov/ct2/show/NCT02931409
Albrich, 2012, Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter post-study survey (ProREAL), Archives of Internal Medicine, 172, 715, 10.1001/archinternmed.2012.770
Arnold, 2005, Interventions to improve antibiotic prescribing practices in ambulatory care, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003539.pub2
Atkins, 2004, Grading quality of evidence and strength of recommendations, BMJ, 328, 1490, 10.1136/bmj.328.7454.1490
Balk, 2017, Effect of procalcitonin testing on health-care utilization and costs in critically ill patients in the United States, Chest, 151, 23, 10.1016/j.chest.2016.06.046
Cals, 2009, Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial, BMJ, 338, b1374, 10.1136/bmj.b1374
Doan, 2014, Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD006452.pub4
Drozdov, 2015, Procalcitonin and pyuria-based algorithm reduces antibiotic use in urinary tract infections: a randomized controlled trial, BMC Medicine, 13, 104, 10.1186/s12916-015-0347-y
Evans, 2002, Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial, Lancet, 359, 1648, 10.1016/S0140-6736(02)08597-5
Gonzales, 1997, Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians, JAMA, 278, 901, 10.1001/jama.1997.03550110039033
Goossens, 2005, Outpatient antibiotic use in Europe and association with resistance: a cross-national database study, Lancet, 365, 579, 10.1016/S0140-6736(05)17907-0
GRADE Working Group, McMaster University GRADEpro GDT 2014
Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
Hoare, 2006, Pneumonia: update on diagnosis and management, BMJ, 332, 1077, 10.1136/bmj.332.7549.1077
Hoeboer, 2015, The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis, Clinical Microbiology and Infection, 21, 474, 10.1016/j.cmi.2014.12.026
Konstantinides, 2008, Clinical practice. Acute pulmonary embolism, New England Journal of Medicine, 359, 2804, 10.1056/NEJMcp0804570
Kumar, 2006, Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock, Critical Care Medicine, 34, 1589, 10.1097/01.CCM.0000217961.75225.E9
Kumar, 2009, Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock, Chest, 136, 1237, 10.1378/chest.09-0087
Kutz, 2015, Prognostic value of procalcitonin in respiratory tract infections across clinical settings, Critical Care (London, England), 19, 74, 10.1186/s13054-015-0792-1
Kutz, 2016, Comparison between B·R·A·H·M·S PCT direct, a new sensitive point-of-care testing device for rapid quantification of procalcitonin in emergency department patients and established reference methods - a prospective multinational trial, Clinical Chemistry and Laboratory Medicine, 54, 577, 10.1515/cclm-2015-0437
Lawrence, 2009, Antimicrobial stewardship in the intensive care unit: advances and obstacles, American Journal of Respiratory and Critical Care Medicine, 179, 434, 10.1164/rccm.200809-1394CP
Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration, Journal of Clinical Epidemiology, 62, e1, 10.1016/j.jclinepi.2009.06.006
Liberati, 2009, Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD000022.pub3
Manzano, 2010, Impact of procalcitonin on the management of children aged 1 to 36 months presenting with fever without source: a randomized controlled trial, American Journal of Emergency Medicine, 28, 647, 10.1016/j.ajem.2009.02.022
Meili, 2015, Management of patients with respiratory infections in primary care: procalcitonin, C-reactive protein or both?, Expert Review of Respiratory Medicine, 9, 587, 10.1586/17476348.2015.1081063
Meili, 2016, Infection biomarkers in primary care patients with acute respiratory tract infections - comparison of procalcitonin and C-reactive protein, BMC Pulmonary Medicine, 16, 43, 10.1186/s12890-016-0206-4
Muller, 2000, Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit, Critical Care Medicine, 28, 977, 10.1097/00003246-200004000-00011
Muller, 2001, Procalcitonin: how a hormone became a marker and mediator of sepsis, Swiss Medical Weekly, 131, 595
Muller, 2010, Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial, Chest, 138, 121, 10.1378/chest.09-2920
Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014
Sager, 2017, Procalcitonin-guided diagnosis and antibiotic stewardship revisited, BMC Medicine, 15, 15, 10.1186/s12916-017-0795-7
Schuetz, 2011, Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms, Archives of Internal Medicine, 171, 1322, 10.1001/archinternmed.2011.318
Schuetz, 2015, Biomarker-guided personalised emergency medicine for all - hope for another hype?, Swiss Medical Weekly, 145, w14079
Schuetz, 2016, Procalcitonin: a new biomarker for the cardiologist, International Journal of Cardiology, 223, 390, 10.1016/j.ijcard.2016.08.204
Schuetz, 2017, Serial procalcitonin predicts mortality in severe sepsis patients: results from the multicenter procalcitonin monitoring sepsis (MOSES) study, Critical Care Medicine, 45, 781, 10.1097/CCM.0000000000002321
Spurling, 2010, Delayed antibiotics for respiratory infections, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD004417.pub3
StataCorp LP Stata Statistical Software: Release 12.1. 2005
Stewart, 2015, Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD Statement, JAMA, 313, 1657, 10.1001/jama.2015.3656
Stojanovic, 2017, Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a Chinese hospital system perspective, Clinical Chemistry and Laboratory Medicine, 55, 561, 10.1515/cclm-2016-0349
Thompson, 2001, Multilevel models for meta-analysis, and their application to absolute risk differences, Statistical Methods in Medical Research, 10, 375, 10.1177/096228020101000602
Turner, 2000, A multilevel model framework for meta-analysis of clinical trials with binary outcomes, Statistics in Medicine, 19, 3417, 10.1002/1097-0258(20001230)19:24<3417::AID-SIM614>3.0.CO;2-L
Vugt, 2013, Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough: diagnostic study, BMJ, 346, f2450, 10.1136/bmj.f2450
Wacker, 2013, Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis, Lancet Infectious Diseases, 13, 426, 10.1016/S1473-3099(12)70323-7
Zaas, 2014, The current epidemiology and clinical decisions surrounding acute respiratory infections, Trends in Molecular Medicine, 20, 579, 10.1016/j.molmed.2014.08.001
Schuetz, 2008, Procalcitonin to initiate or withhold antibiotics in acute respiratory tract infections, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD007498
Schuetz, 2010, Procalcitonin for guidance of antibiotic therapy, Expert Review of Anti-Infective Therapy, 8, 575, 10.1586/eri.10.25
Schuetz, 2011, Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms, Archives of Internal Medicine, 171, 1322, 10.1001/archinternmed.2011.318